Source: Annual Congress 2012 - Hot topics in respiratory infections
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
P.M. Lepper, S.R. Ott, E. Nüesch, M. von Eynatten, C. Schumann, M.W. Pletz, N. Mealing, T. Welte, T.T. Bauer, N. Suttorp, P. Jüni, R. Bals, G. Rohde (Homburg, Munich, Ulm, Jena, Berlin, Germany; Bern, Switzerland; Maastricht, Netherlands). Admission serum glucose levels are a risk factor predicting short- and long-term mortality in community acquired pneumonia. Eur Respir J 2012; 40: Suppl. 56, 2814

Member's Comments

No comment yet.

Related content which might interest you: Do admission glucose levels aid in predicting mortality associated with community-acquired pneumonia? Source: Eur Respir J, 50 (4) 1700307; 10.1183/13993003.00307-2017 Year: 2017 Admission glucose concentrations independently predict early mortality in patients with community-acquired pneumonia Source: Eur Respir J 2007; 30: Suppl. 51, 482s Year: 2007 Excess age dependent short- and long-term mortality in patients with community acquired pneumonia Source: Annual Congress 2008 - Factors related to outcome of community-acquired pneumonia Year: 2008 Mortality after hospitalisation for COVID19, and identification of prognostic factors on admission that increase mortality risk Source: Virtual Congress 2021 – COVID - 19 Year: 2021 Ability of the reduced severity rule crb-65 to detect high risk of short-term mortality from pneumonia in elderly patients Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers Year: 2009 Circulating fetuin-A as a biomarker predicting mortality in ICU septic patients Source: International Congress 2017 – Sepsis, infections, ARDS and beyond Year: 2017 Assessment of prognostic scores for 30-day mortality prediction in hospitalised patients with health care associated pneumonia (HCAP) Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity Year: 2010 Does the serum C-reactive protein (CRP) predict adverse outcomes in patients admitted with community acquired pneumonia? Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011 COPD is an independent risk factor for mortality in community acquired pneumonia Source: Annual Congress 2007 - Severity scores and comorbidities in community-acquired pneumonia Year: 2007 Admission clinical parameters in predicting in-hospital mortality in COVID-19 Source: Virtual Congress 2021 – COVID - 19 biomarkers Year: 2021 The effect of nutritional risk on mortality in respiratory ICU patients Source: Virtual Congress 2020 – Novel findings in intensive care unit medicine: part 2 Year: 2020 Admission lactate predicts poor prognosis independently of the CRB/CURB-65 scores in community-acquired pneumonia. Source: International Congress 2017 – Update on community acquired pneumonia Year: 2017 The impact on risk-factor analysis of different mortality outcomes in COPD patients Source: Eur Respir J 2008; 32: 629-636 Year: 2008 Convalescent Plasma does not improve in-hospital mortality among low SARS-CoV-2-IgG antibodies in COVID-19 hospitalized patients Source: Virtual Congress 2021 – COVID - 19 treatments Year: 2021 The prognostic importance of plasma D-dimer levels in patients with community acquired pneumonia Source: Annual Congress 2007 - Prognostic laboratory tests in community-acquired pneumonia Year: 2007 Serum KL-6 as a biomarker to assess risk of worse outcome in patients with SARS-CoV2 infection Source: Virtual Congress 2021 – COVID - 19 biomarkers Year: 2021 Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 groups at risk Source: Eur Respir J 2007; 30: Suppl. 51, 481s Year: 2007 Prognostic power of biomarkers to predict in-hospital and postdischarge mortality in community acquired pneumonia Source: Annual Congress 2013 –A modern approach to lung diseases: from bronchi to pleura Year: 2013 Comparison of prospective scores for predicting mortality and hospital admission in hospitalised patients and out-patients with CAP Source: Annual Congress 2005 - Community-acquired pneumonia: clinical approaches Year: 2005 Interleukin-6 levels as an evolution marker of late mortality and cardiovascular events after an episode of community-acquired pneumonia. Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection Year: 2018